RhumbLine Advisers
NAUT icon

RhumbLine Advisers’s Nautilus Biotechnolgy NAUT Stock Holding History

RhumbLine Advisers’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.4K Buy
+36,567
New +$96.5K ﹤0.01% 3627
2025
Q2 		– Sell
-69,755
Closed -$60K – 4217
2025
Q1 		$60K Sell
69,755
-3,628
-5% -$5.39K ﹤0.01% 3533
2024
Q4 		$123K Buy
73,383
+2,497
+4% +$5.97K ﹤0.01% 3411
2024
Q3 		$202K Sell
70,886
-3,729
-5% -$9.65K ﹤0.01% 3236
2024
Q2 		$175K Sell
74,615
-243
-0.3% -$634 ﹤0.01% 3304
2024
Q1 		$220K Buy
74,858
+1,928
+3% +$5.47K ﹤0.01% 3132
2023
Q4 		$218K Sell
72,930
-1,195
-2% -$3.42K ﹤0.01% 3141
2023
Q3 		$234K Buy
74,125
+2,677
+4% +$8.71K ﹤0.01% 3073
2023
Q2 		$277K Buy
71,448
+668
+0.9% +$1.92K ﹤0.01% 3065
2023
Q1 		$196K Buy
70,780
+1,394
+2% +$2.92K ﹤0.01% 2740
2022
Q4 		$125K Buy
69,386
+392
+0.6% +$757 ﹤0.01% 2876
2022
Q3 		$146K Buy
68,994
+3,763
+6% +$9.46K ﹤0.01% 2953
2022
Q2 		$175K Buy
+65,231
New +$243K ﹤0.01% 2965

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

RhumbLine Advisers's NAUT Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 36,567 shares worth $68.4K. The stake represents ﹤0.01% of the portfolio and ranks #3627 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in NAUT as recently as Q1 2025.

RhumbLine Advisers first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $277K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • RhumbLine Advisers held 36,567 shares of Nautilus Biotechnolgy worth $68.4K as of Q2 2026.
  • Nautilus Biotechnolgy was a new RhumbLine Advisers position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3627 holding.
  • RhumbLine Advisers first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
  • RhumbLine Advisers's Nautilus Biotechnolgy position peaked at $277K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.